AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2004
Jun 2, 2004
33341_dirs_2004-06-02_7282859a-9435-4dc2-a616-69e897347912.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCI)
CIK: 0000070487
Period of Report: 2004-05-27
Reporting Person: RAASCH JONA S (VP & Chief Operations Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-05-27 | Common Stock | S | 90 | $16.45 | Disposed | 0 | Indirect |
| 2004-05-27 | Common Stock | S | 50 | $16.45 | Disposed | 50 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 66090 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $4.00 | 2004-12-13 | Common Stock (5000) | 5000 | Direct |
| Employee Stock Option (Right to Buy) | $5.75 | 2006-12-04 | Common Stock (10435) | 10435 | Direct |
| Employee Stock Option (Right to Buy) | $11.00 | 2013-06-26 | Common Stock (34091) | 34091 | Direct |
| Employee Stock Option (Right to Buy) | $16.10 | 2014-01-05 | Common Stock (13388) | 13388 | Direct |
Footnotes
F1: This option became exercisable in 33-1/3% increments on December 13, 2000, 2001 and 2002, respectively.
F2: This option becomes exercisable in 33-1/3% increments on December 4, 2002, 2003 and 2004, respectively.
F3: This option becomes fully exercisable on June 26, 2008.
F4: This option becomes fully exercisable on January 5, 2009.
More from NATIONAL RESEARCH CORP
Capital/Financing Update
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Earnings Release
2026
Apr 28
Regulatory Filings
2026
Apr 20